Viridian Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 05/12/2025 | 12.22 M | $164.77 M | 2.87% | 15.03% |
BLACKROCK, INC. | 05/02/2025 | 5.71 M | $76.95 M | -0.88% | 7.02% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 5.38 M | $72.53 M | 18.96% | 6.61% |
KYNAM CAPITAL MANAGEMENT, LP | 05/15/2025 | 4.70 M | $63.36 M | 41.30% | 5.78% |
VANGUARD GROUP INC | 05/09/2025 | 4.56 M | $61.51 M | -0.70% | 5.61% |
VR ADVISER, LLC | 05/15/2025 | 3.88 M | $52.34 M | 0.00% | 4.77% |
COMMODORE CAPITAL LP | 05/15/2025 | 3.60 M | $48.53 M | 50.00% | 4.43% |
STATE STREET CORP | 05/15/2025 | 2.87 M | $38.63 M | -18.65% | 3.52% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.79 M | $37.65 M | 12.03% | 3.43% |
NOVO HOLDINGS A/S | 05/15/2025 | 2.25 M | $30.33 M | 0.01% | 2.77% |
PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 2.10 M | $28.24 M | 15.11% | 2.58% |
MAVERICK CAPITAL LTD | 05/15/2025 | 2.06 M | $27.79 M | 0.36% | 2.53% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 2.02 M | $27.25 M | -11.60% | 2.49% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.72 M | $23.20 M | 3.71% | 2.12% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.69 M | $22.76 M | 27.23% | 2.08% |
EVERSEPT PARTNERS, LP | 05/15/2025 | 1.38 M | $18.57 M | 76.63% | 1.69% |
LOOMIS SAYLES & CO L P | 05/14/2025 | 1.37 M | $18.47 M | -2.14% | 1.68% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.27 M | $17.13 M | -32.27% | 1.56% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.25 M | $16.83 M | 0.00% | 1.54% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 1.23 M | $16.60 M | 33.80% | 1.51% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.11 M | $15.02 M | -33.26% | 1.37% |
MARSHALL WACE, LLP | 05/15/2025 | 1.08 M | $14.61 M | 100.00% | 1.33% |
PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 1.06 M | $14.35 M | -2.13% | 1.31% |
VIVO CAPITAL, LLC | 05/12/2025 | 982.58 K | $13.25 M | 0.00% | 1.21% |
CANDRIAM S.C.A. | 05/14/2025 | 880.43 K | $11.87 M | 20.41% | 1.08% |
WOODLINE PARTNERS LP | 05/15/2025 | 813.65 K | $10.97 M | 0.00% | 1.00% |
GREAT POINT PARTNERS LLC | 05/15/2025 | 750.00 K | $10.11 M | 0.00% | 0.92% |
NORTHERN TRUST CORP | 05/13/2025 | 702.52 K | $9.47 M | 1.21% | 0.86% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 659.66 K | $8.89 M | -55.62% | 0.81% |
ROSALIND ADVISORS, INC. | 05/14/2025 | 595.00 K | $8.02 M | 100.00% | 0.73% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 565.96 K | $7.63 M | -1.58% | 0.70% |
VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 552.85 K | $7.45 M | 34.70% | 0.68% |
FISHER ASSET MANAGEMENT, LLC | 05/14/2025 | 537.02 K | $7.24 M | 3.67% | 0.66% |
UBS GROUP AG | 05/13/2025 | 504.19 K | $6.80 M | -1.54% | 0.62% |
YIHENG CAPITAL MANAGEMENT, L.P. | 05/16/2025 | 500.26 K | $6.74 M | -33.32% | 0.62% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 494.95 K | $6.67 M | 5.32% | 0.61% |
OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 450.00 K | $6.07 M | -48.28% | 0.55% |
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 05/06/2025 | 423.27 K | $5.71 M | 0.00% | 0.52% |
DEUTSCHE BANK AG\ | 05/09/2025 | 396.81 K | $5.35 M | -1.51% | 0.49% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 390.00 K | $5.26 M | 144.34% | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 05/01/2025 | 362.89 K | $4.89 M | 579.89% | 0.45% |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 354.74 K | $4.78 M | 40.20% | 0.44% |
MORGAN STANLEY | 05/15/2025 | 341.80 K | $4.61 M | -53.76% | 0.42% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 320.30 K | $4.32 M | -13.71% | 0.39% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 318.24 K | $4.29 M | 1.42% | 0.39% |
JPMORGAN CHASE & CO | 05/12/2025 | 298.55 K | $4.02 M | -1.90% | 0.37% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 297.97 K | $4.02 M | -18.58% | 0.37% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 249.17 K | $3.36 M | 11.00% | 0.31% |
05/12/2025 | 248.63 K | $3.35 M | 100.00% | 0.31% | |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 222.40 K | $3.00 M | -47.61% | 0.27% |
Viridian Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 198 institutional investors and hedge funds held shares of Viridian Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 12.22 M
BlackRock, Inc.: 5.71 M
Deep Track Capital, LP: 5.38 M
Kynam Capital Management, LP: 4.7 M
VANGUARD GROUP INC: 4.56 M
VR Adviser, LLC: 3.88 M
107.04% of Viridian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 93.91 M shares in the last 24 months. This purchase volume represents approximately $1.60 B in transactions.